HOOKIPA Pharma Inc (HOOK)
3.82
+0.07
(+1.87%)
USD |
NASDAQ |
Nov 05, 10:23
HOOKIPA Pharma Max Drawdown (5Y): 98.13% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.13% |
| September 30, 2024 | 97.85% |
| August 31, 2024 | 97.84% |
| July 31, 2024 | 97.84% |
| June 30, 2024 | 97.84% |
| May 31, 2024 | 97.84% |
| April 30, 2024 | 97.84% |
| March 31, 2024 | 97.84% |
| February 29, 2024 | 97.84% |
| January 31, 2024 | 97.84% |
| December 31, 2023 | 97.84% |
| November 30, 2023 | 97.84% |
| October 31, 2023 | 97.80% |
| September 30, 2023 | 97.02% |
| August 31, 2023 | 96.64% |
| July 31, 2023 | 96.38% |
| June 30, 2023 | 96.38% |
| May 31, 2023 | 96.38% |
| April 30, 2023 | 96.38% |
| March 31, 2023 | 96.31% |
| February 28, 2023 | 96.26% |
| January 31, 2023 | 96.26% |
| December 31, 2022 | 96.26% |
| November 30, 2022 | 94.87% |
| October 31, 2022 | 94.11% |
| Date | Value |
|---|---|
| September 30, 2022 | 93.54% |
| August 31, 2022 | 93.54% |
| July 31, 2022 | 93.54% |
| June 30, 2022 | 93.54% |
| May 31, 2022 | 93.54% |
| April 30, 2022 | 93.54% |
| March 31, 2022 | 93.54% |
| February 28, 2022 | 93.54% |
| January 31, 2022 | 93.13% |
| December 31, 2021 | 88.06% |
| November 30, 2021 | 83.50% |
| October 31, 2021 | 75.81% |
| September 30, 2021 | 69.81% |
| August 31, 2021 | 67.15% |
| July 31, 2021 | 61.92% |
| June 30, 2021 | 58.30% |
| May 31, 2021 | 58.30% |
| April 30, 2021 | 58.30% |
| March 31, 2021 | 58.30% |
| February 28, 2021 | 58.30% |
| January 31, 2021 | 58.30% |
| December 31, 2020 | 58.30% |
| November 30, 2020 | 58.30% |
| October 31, 2020 | 58.30% |
| September 30, 2020 | 58.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
56.47%
Minimum
Nov 2019
98.13%
Maximum
Oct 2024
81.20%
Average
93.54%
Median
Feb 2022
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -59.07 |
| Beta (5Y) | 0.8369 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 86.05% |
| Historical Sharpe Ratio (5Y) | -0.5609 |
| Historical Sortino (5Y) | -1.232 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.62% |